Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Sciubba

Neurological Surgery Baltimore, MD Medical Doctor

NPI 1043357270 CMS profile 138478

600 N Wolfe St, Meyer Building 8-161, Baltimore, MD 21287

Open in the dashboard

General payments

$788,780

569 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$49,200 paid to institutions, not to them · program year 2020

Through program year 2025, Daniel Sciubba of Baltimore, MD is reported in the CMS Open Payments database as having received $788,780 across 569 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $49,200 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $241,452 164
2024 General $96,125 92
2023 General $83,286 78
2022 General $131,413 98
2021 General $87,233 56
2020 General $64,112 23
2019 General $85,159 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Sciubba
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Daniel Sciubba were reported at $241,452. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Daniel Sciubba Neurological Surgery median Middle half National median
2019 $85,159 $582 $138–$3,006 $163
2020 $64,112 $294 $76–$2,174 $114
2021 $87,233 $387 $105–$2,432 $132
2022 $131,413 $542 $139–$2,989 $149
2023 $83,286 $534 $145–$2,697 $160
2024 $96,125 $574 $155–$3,046 $164
2025 $241,452 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Products, Inc. $166,966 107 payments
  2. Baxter Healthcare $139,472 43 payments
  3. Medical Device Business Services, Inc. $137,020 69 payments
  4. Stryker Corporation $99,727 70 payments
  5. Medtronic, Inc. $64,664 53 payments
  6. Pacira Pharmaceuticals Incorporated $47,679 12 payments
  7. icotec Medical Inc. $40,882 46 payments
  8. Augmedics Inc. $28,743 8 payments
  9. Medtronic USA, Inc. $18,507 16 payments
  10. SI-BONE, Inc. $16,725 27 payments
  11. Other $28,395 118 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $542,128 124 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $75,735 11 payments
  3. Royalty or License $67,970 3 payments
  4. Travel and Lodging $52,627 144 payments
  5. Current or prospective ownership or investment interest $27,040 1 payment
  6. Food and Beverage $16,459 277 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $5,750 5 payments
  8. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $1,000 1 payment
  9. Entertainment $55 1 payment
  10. Education $16 2 payments
Products named General payments · program years 2019–2025
  1. CONFIDENCE SPINAL CEMENT SYSTEM $158,625 38 payments
  2. CONDUIT $149,609 44 payments
  3. SYMPHONY $149,246 47 payments
  4. Xvision $143,715 40 payments
  5. VIPER $105,945 20 payments
  6. TISSEEL $78,358 10 payments
  7. TRIALTIS $68,177 14 payments
  8. Exparel $47,679 12 payments
  9. CONFIDENCE $46,078 16 payments
  10. FLOSEAL $39,399 14 payments
  11. Other $433,004 422 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$105,849

Medicare's payments for the services billed

Medicare patients

69

Average age 74

Services billed

250

33 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 38%
Osteoporosis 28%
Cancer 23%
Diabetes 22%
Depression 19%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $15,042
$15,042 — —
Zilretta
  • Pacira Pharmaceuticals Incorporated $1,267
$1,267 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

569 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record